LGALS9 and exocrine pancreatic carcinoma: Since this publication, the contribution of gal-9 to immune evasion has been reported in a number of other malignancies as diverse as lung, breast and pancreatic carcinomas, melanomas and acute myeloid leukemias3,6–9.